FDA approves first weight-loss pill

Published: Tuesday, December 23, 2025 at 2:31 am

FDA Approves First Oral Weight-Loss Pill, Offering New Treatment Option

The Food and Drug Administration (FDA) has approved a new weight-loss pill, marking a significant development in the treatment of obesity. The pill, developed by a Danish drugmaker, is expected to launch in the United States in early January, with an initial monthly cost of $149 for the first dose.

According to the drugmaker's CEO, the pill offers a convenient, once-daily alternative to the existing Wegovy injection, promising comparable weight loss results. The pill is the first oral GLP-1 treatment available for individuals struggling with overweight or obesity. Clinical trials have shown that the weight loss achieved with the pill is equivalent to that of the Wegovy injections, both containing the same active ingredient, semaglutide.

The development of this new treatment comes amid broader efforts to address the obesity epidemic. The former administration, under President Donald Trump, actively sought to lower the cost and expand the availability of weight-loss and diabetes medications. This included agreements with pharmaceutical companies to reduce prices and increase coverage under Medicare.

BNN's Perspective:

The approval of this oral weight-loss medication is a welcome development, providing a new option for individuals seeking to manage their weight. While the convenience of a pill form is undeniable, it's crucial to consider the long-term implications of such treatments, including potential side effects and the importance of a holistic approach to weight management that includes lifestyle changes. The focus on affordability and accessibility, as seen in the previous administration's efforts, is also critical to ensuring that effective treatments are available to those who need them.

Keywords: FDA, weight-loss pill, Wegovy, oral GLP-1, obesity, semaglutide, treatment, medication, United States, Medicare, Donald Trump, Novo Nordisk, Eli Lilly, weight loss, diabetes

Full Story